Q & A: Kiniksa Pharmaceuticals
Q: Do you have any recent news from Kiniksa Pharmaceuticals? 

A: Kiniksa Pharmaceuticals (KNSA) is a biopharmaceutical company that aims at  improving the lives of patients with debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need. The firm  focuses on cardiovascular indications.

Kiniksa’s portfolio of assets is based on strong . . .